Responses
Oesophagus
A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease
Compose a Response to This Article
Other responses
No responses have been published for this article.